VSL#3 Versus Placebo in Maintenance of Remission in Crohn's Disease

Clinical Trial ID NCT00114465

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00114465

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004 6.47
2 Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003 4.40
3 Intestinal permeability in Crohn's disease patients and their first degree relatives. Dig Liver Dis 2001 2.20
4 Review article: treatment of mild to moderate ulcerative colitis and pouchitis. Aliment Pharmacol Ther 2002 0.86
5 Diagnosis and treatment of pouchitis. Best Pract Res Clin Gastroenterol 2003 0.75
Next 100